Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed - a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

By Ornstein D.K.   Smith D.S.   Andriole G.L.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1094-1097

Elsevier

Access to resources Recommend Favorite

Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity

By Luo S.   Martel C.   Chen C.   Labrie C.   Candas B.   Singh S.M.   Labrie F.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 913-919

Elsevier

Access to resources Recommend Favorite

Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization

By Kemppainen J.A.   Wilson E.M.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 157-163

Elsevier

Access to resources Recommend Favorite

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

By Higano C.S.   Ellis W.   Russell K.   Lange P.H.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 800-804

Elsevier

Access to resources Recommend Favorite

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

By Brufsky A.   Fontaine-Rothe P.   Berlane K.   Rieker P.   Jiroutek M.   Kaplan I.   Kaufman D.   Kantoff P.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 913-920

Elsevier

Access to resources Recommend Favorite